Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperparathyroidism, Primary × evocalcet × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parathyroid Neoplasms 1 Hyperparathyroidism, Primary 1

Interventions

Cinacalcet 3 Parathyroidectomy 2 fluorocholine 1 evocalcet 1 Tablets 1 Sodium Chloride 1 Rubidium-82 1 Denosumab 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03280264 2021-05-27

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

Kyowa Kirin Co., Ltd.

Phase 3 Completed

18 enrolled 13 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡